Maze Therapeutics, Inc.
MAZE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $196,812 | $29,158 | $99,919 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $4,859 | $4,952 | $6,230 |
| Total Curr. Assets | $201,671 | $34,110 | $106,149 |
| Property Plant & Equip (Net) | $29,918 | $34,984 | $41,228 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $1,088 | $1,088 | $1,210 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $7,865 | $1,322 | $1,370 |
| Total NC Assets | $38,871 | $37,394 | $43,808 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $240,542 | $71,504 | $149,957 |
| Liabilities | – | – | – |
| Payables | $1,939 | $2,019 | $1,585 |
| Short-Term Debt | $4,632 | $4,489 | $4,324 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $14,102 | $9,808 | $14,874 |
| Total Curr. Liab. | $20,673 | $16,316 | $20,783 |
| LT Debt | $21,996 | $45,134 | $27,731 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $969 | $0 | $0 |
| Total NC Liab. | $22,965 | $45,134 | $27,731 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $26,628 | $29,543 | $32,055 |
| Total Liabilities | $43,638 | $61,450 | $48,514 |
| Equity | – | – | – |
| Pref Stock | $508,087 | $383,902 | $383,902 |
| Common Stock | $2 | $22 | $21 |
| Retained Earnings | -$358,427 | -$395,686 | -$295,271 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $47,242 | $21,816 | $12,791 |
| Total Equity | $196,904 | $10,054 | $101,443 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $240,542 | $71,504 | $149,957 |
| Net Debt | -$170,184 | $20,465 | -$67,864 |